Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Sutro Biopharma, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 2 |
| Sutro Biopharma, Inc., Pharmaceuticals &Healthcare, Deal Details | 11 | 20 |
| Venture Financing | 11 | 1 |
| SutroVax Raises Funds Through Initial Financing Round | 11 | 1 |
| Sutro Biopharma Raises US$26 Million In Series D Financing | 12 | 2 |
| Sutro Biopharma Raises US$16.5 Million In Second Tranche Of Series C Financing | 14 | 2 |
| Sutro Biopharma Raises US$20 Million In First Tranche Of Series C Financing | 16 | 2 |
| Partnerships | 18 | 1 |
| Sutro Enters into Co-Development Agreement with Celgene | 18 | 2 |
| Sutro Biopharma Enters into Agreement with University of California, San Francisco | 20 | 1 |
| Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center | 21 | 2 |
| Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur | 23 | 1 |
| Sutro Biopharma Enters Into Co-Development Agreement With Celgene | 24 | 2 |
| Sutro Biopharma Enters Into Collaboration With Pfizer | 26 | 1 |
| Licensing Agreements | 27 | 1 |
| EMD Serono Enters into Licensing Agreement with Sutro Biopharma | 27 | 2 |
| EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology | 29 | 1 |
| Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry | 30 | 1 |
| Sutro Biopharma, Inc. - Key Competitors | 31 | 1 |
| Key Employees | 32 | 1 |
| Locations And Subsidiaries | 33 | 1 |
| Head Office | 33 | 1 |
| Other Locations &Subsidiaries | 33 | 1 |
| Appendix | 34 | 1 |
| Methodology | 34 | 1 |
| About GlobalData | 34 | 1 |
| Contact Us | 34 | 1 |
| Disclaimer | 34 | 1 |